Your provider may adjust your dose or prescribe antiemetic medication
But just a few weeks later, Blue Cross Blue Shield of Massachusetts announced that effective January 2026, they would cease covering GLP-1s entirely for weight loss for their fully insured population
Rather than increasing medication on a fixed schedule, Nooms physician-designed protocol adjusts dosing based on each patients individual progress and response
Semaglutide activates GLP-1 receptors, enhancing insulin secretion, suppressing glucagon, and reducing appetite through one set of neural pathways
Patients who prioritize sleep (79 hours nightly), manage stress, and avoid refined carbohydrates and ultra-processed foods consistently report faster weight loss than those using tirzepatide alone without lifestyle changes
Rather than focusing solely on one aspect of how the body functions, it works through multiple pathways simultaneously